Glycemic deviation index: a novel method of integrating glycemic numerical value and variability
- PMID: 33736619
- PMCID: PMC7976707
- DOI: 10.1186/s12902-021-00691-z
Glycemic deviation index: a novel method of integrating glycemic numerical value and variability
Abstract
Background: There are many continuous blood glucose monitoring (CGM) data-based indicators, and most of these focus on a single characteristic of abnormal blood glucose. An ideal index that integrates and evaluates multiple characteristics of blood glucose has not yet been established.
Methods: In this study, we proposed the glycemic deviation index (GDI) as a novel integrating characteristic, which mainly incorporates the assessment of the glycemic numerical value and variability. To verify its effectiveness, GDI was applied to the simulated 24 h glycemic profiles and the CGM data of type 2 diabetes (T2D) patients (n = 30).
Results: Evaluation of the GDI of the 24 h simulated glycemic profiles showed that the occurrence of hypoglycemia was numerically the same as hyperglycemia in increasing GDI. Meanwhile, glycemic variability was added as an independent factor. One-way ANOVA results showed that the application of GDI showed statistically significant differences in clinical glycemic parameters, average glycemic parameters, and glycemic variability parameters among the T2D groups with different glycemic levels.
Conclusions: In conclusion, GDI integrates the characteristics of the numerical value and the variability in blood glucose levels and may be beneficial for the glycemic management of diabetic patients undergoing CGM treatment.
Keywords: Continuous glucose monitoring; Diabetes; Glycemic variability.
Conflict of interest statement
Yizhou Zou, Wanli Wang, Dongmei Zheng, and Xu Hou declare that there are no conflicts of interest.
Figures


Similar articles
-
Characterizing blood glucose variability using new metrics with continuous glucose monitoring data.J Diabetes Sci Technol. 2011 Jul 1;5(4):871-8. doi: 10.1177/193229681100500408. J Diabetes Sci Technol. 2011. PMID: 21880228 Free PMC article.
-
The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes.BMC Endocr Disord. 2021 Apr 23;21(1):79. doi: 10.1186/s12902-021-00742-5. BMC Endocr Disord. 2021. PMID: 33888117 Free PMC article. Clinical Trial.
-
Simple Linear Support Vector Machine Classifier Can Distinguish Impaired Glucose Tolerance Versus Type 2 Diabetes Using a Reduced Set of CGM-Based Glycemic Variability Indices.J Diabetes Sci Technol. 2020 Mar;14(2):297-302. doi: 10.1177/1932296819838856. Epub 2019 Mar 31. J Diabetes Sci Technol. 2020. PMID: 30931604 Free PMC article.
-
Research progress on the association between glycemic variability index derived from CGM and cardiovascular disease complications.Acta Diabetol. 2024 Jun;61(6):679-692. doi: 10.1007/s00592-024-02241-0. Epub 2024 Mar 12. Acta Diabetol. 2024. PMID: 38467807 Review.
-
Diabetic Kidney Disease: Is There a Role for Glycemic Variability?Curr Diab Rep. 2018 Feb 15;18(3):13. doi: 10.1007/s11892-018-0979-3. Curr Diab Rep. 2018. PMID: 29450720 Review.
Cited by
-
The characteristics of postprandial glycemic response patterns to white rice and glucose in healthy adults: Identifying subgroups by clustering analysis.Front Nutr. 2022 Oct 31;9:977278. doi: 10.3389/fnut.2022.977278. eCollection 2022. Front Nutr. 2022. PMID: 36386904 Free PMC article.
-
Statistical Packages and Algorithms for the Analysis of Continuous Glucose Monitoring Data: A Systematic Review.J Diabetes Sci Technol. 2025 May;19(3):787-809. doi: 10.1177/19322968231221803. Epub 2024 Jan 5. J Diabetes Sci Technol. 2025. PMID: 38179940 Free PMC article.
References
-
- Gorst C, Kwok CS, Aslam S, Buchan I, Kontopantelis E, Myint PK, Heatlie G, Loke Y, Rutter MK, Mamas MA. Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis. Diabetes Care. 2015;38(12):2354–2369. - PubMed
-
- Skrha J, Soupal J, Skrha J, Jr, Prazny M. Glucose variability, HbA1c and microvascular complications. Rev Endocr Metab Disord. 2016;17(1):103–110. - PubMed
-
- Frontoni S, Di Bartolo P, Avogaro A, Bosi E, Paolisso G, Ceriello A. Glucose variability: an emerging target for the treatment of diabetes mellitus. Diabetes Res Clin Pract. 2013;102(2):86–95. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical